BSECompany Update7 Aug 2026 · 7 Aug 2026, 01:44 pm
Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026
Neuland Laboratories Ltd · 524558
✦ AI SummaryMgmt Change
Neuland Laboratories Ltd has announced a schedule of analyst/institutional investor meetings on August 12, 2026, at Emkay Confluence 2026 in Mumbai.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
adc6a7a8-7303-45c5-8e3e-a0a337794108.pdf
View document text
August 7, 2026
BSE Limited The National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza,
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 001
Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst /
Institutional Investor Meetings
This is to inform you that the Company’s management will be participating in the following group
analyst/ investor meeting(s):
Date Name of the Analyst / Location Nature of the
Institutional Investor / Event meeting
August 12, 2026 Emkay Confluence 2026 Mumbai Group meet /
One-on-One meet
Please note that the schedule & participant list of the aforesaid meeting(s) is subject to change
due to any exigencies on the part of Participants / Company.
This is for your information and records.
Thanking you
Yours Sincerely,
For Neuland Laboratories Limited
Sarada Bhamidipati
Company Secretary